More research is needed to better understand how antidepressants work and their efficacy, especially when taken over the ...

People in a new study who took psilocybin often experienced headache, nausea, anxiety, dizziness and elevated blood pressure ...

Magnus Medical announces the commercial launch of its groundbreaking SAINT® neuromodulation system for the treatment of major ...

Shares of the biotech rose about 5% after a medicine licensed from Takeda hit the main and key secondary goals of a mid-stage study focused on major depressive disorder.

Saturday is National Drug Take Back Day and we've got everything you need to know about why and the risks of holding onto ...

The U.S. Food and Drug Administration (FDA) approved Zepbound for the treatment of obesity in November 2023. Some prescribe ...

Some people fear that new obesity drugs will inevitably prove to be dangerous, but there are key distinctions from the ...

Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.

Neurocrine Biosciences has nabbed a phase 2 win, with its investigational med in-licensed from Takeda significantly reducing ...

A group of House lawmakers on Tuesday backed a proposal to ban the drug tianeptine, which has garnered the nickname “gas ...

Drug Take Back Day is Saturday. It's goal is to provide a safe, convenient and responsible means of disposing medications ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental ​The Drug Enforcement Administration (DEA) hosts its latest National Prescription Drug Take Back Day on Saturday, April ...